The Supreme Court will hear on Tuesday a major challenge to the abortion pill brought by doctors and medical associations. In FDA v. Alliance for Hippocratic Medicine, one of two cases on abortion the Supreme Court will hear this term since overturning Roe v. Wade in 2022, the justices will consider the U.S. Food and Drug Administration’s (FDA) decision to roll back safety regulations for the chemical abortion drug mifepristone. Doctors who sued the FDA contend that the removal of safety standards once deemed “essential” makes it more likely women will require medical treatment, forcing OB-GYN…